Skip to content
healthcare.dev

OLMESARTAN MEDOXOMIL

NDC 60290-010, OLMESARTAN MEDOXOMIL, tablet, from Umedica Laboratories USA Inc..

Product NDC
60290-010
Status
Listed
Labeler
Umedica Laboratories USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207135
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60290-010 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLMESARTAN MEDOXOMIL20 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]

Package NDCNDC-11Package
60290-010-016029000100130 TABLET in 1 BOTTLE (60290-010-01)
60290-010-026029000100290 TABLET in 1 BOTTLE (60290-010-02)
60290-010-036029000100310 TABLET in 1 BLISTER PACK (60290-010-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c49a7f23-2af0-4607-9f21-114970f8630d

Use it

Look up 60290-010 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60290-010 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60290-010. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.